Evidence map›Paper›PMID 22459147›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2012

A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice.

Ko-Eun Choi, Casey L Hall, Jin-Mei Sun, Ling Wei, Osama Mohamad, Thomas A Dix, Shan P Yu

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Protective effects of GPR37FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  14. Optochemogenetic Stimulation of Transplanted iPS-NPCs Enhances Neuronal Repair and Functional Recovery after Ischemic Stroke.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  15. Review
  16. Neuroprotective and regenerative roles of intranasal Wnt-3a administration after focal ischemic stroke in mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ko-Eun ChoiDepartment of Anesthesiology, Emory University School ofMedicine, Atlanta, Georgia 30322, USA.
Casey L Hall
Jin-Mei Sun
Ling Wei
Osama Mohamad
Thomas A Dix
Shan P Yu
Emory University · USMedical University of South Carolina · USPalmetto Pharmaceuticals (United States) · US

Funding

Novel Neurotensin Analogs as AntischizophrenicsR44MH065099 · NIMH · HALIMED PHARMACEUTICALS, INC. · PI DIX, THOMAS A. · 2005 to 2012
$4.3M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2002 to 2002
$2.0M
Transplantation of Pre-conditioned Bone Marrow Mesenchymal Stem Cells after IscheR01NS062097 · NINDS · EMORY UNIVERSITY · PI WEI, LING · 2010 to 2014
$1.7M
Combination therapy in human ES cell transplantation after neonatal strokeR01NS058710 · NINDS · EMORY UNIVERSITY · PI WEI, LING · 2009 to 2012
$1.3M
Neuroprotection NR3A in Cultured Neurons and Ischemic NeonatesR01NS057255 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, SHAN P. · 2007 to 2011
$1.1M
Stroke Treatment by Chemically-Induced HypothermiaR41NS073378 · NINDS · HALIMED PHARMACEUTICALS, INC. · PI DIX, THOMAS A., YU, SHAN P. · 2011 to 2012
$884k
Development of Neurotensin-based AnalgesicsR43GM079044 · NIGMS · ARGOLYN BIOSCIENCE, INC. · PI DIX, THOMAS A · 2006 to 2006
$164k
Novel Neurotensin Analogs as AntischizoprenicsR41MH065099 · NIMH · ARGOLYN BIOSCIENCE, INC. · PI DIX, THOMAS A · 2002 to 2002
$139k
NCRR NIH HHS C06 RR015455NIGMS NIH HHS GM079044NIGMS NIH HHS R43 GM079044NIMH NIH HHS MH65099NIMH NIH HHS R41 MH065099NIMH NIH HHS R44 MH065099NINDS NIH HHS NS057255NINDS NIH HHS NS058710NINDS NIH HHS NS062097NINDS NIH HHS R01 NS057255NINDS NIH HHS R01 NS058710NINDS NIH HHS R01 NS062097NINDS NIH HHS R41 NS073378NINDS NIH HHS R41NS073378PHS HHS P51
6 · The paper itself

Abstract

Compelling evidence from preclinical and clinical studies has shown that mild to moderate hypothermia is neuroprotective against ischemic stroke. Clinical applications of hypothermia therapy, however, have been hindered by current methods of physical cooling, which is generally inefficient and impractical in clinical situations. In this report, we demonstrate the potential of pharmacologically induced hypothermia (PIH) by the novel neurotensin receptor 1 (NTR1) agonist ABS-201 in a focal ischemic model of adult mice. ABS-201 (1.5-2.5 mg/kg, i.p.) reduces body and brain temperature by 2-5°C in 15-30 min in a dose-dependent manner without causing shivering or altering physiological parameters. Infarct volumes at 24 h after stroke are reduced by ∼30-40% when PIH therapy is initiated either immediately after stroke induction or after 30-60 min delay. ABS-201 treatment increases bcl-2 expression, decreases caspase-3 activation, and TUNEL-positive cells in the peri-infarct region, and suppresses autophagic cell death compared to stroke controls. The PIH therapy using ABS-201 improves recovery of sensorimotor function as tested 21 d after stroke. These results suggest that PIH induced by neurotensin analogs represented by ABS-201 are promising candidates for treatment of ischemic stroke and possibly for other ischemic or traumatic injuries.

Indexed as

AnimalsApoptosisAutophagyBody TemperatureBrain IschemiaCerebral InfarctionCerebrovascular CirculationDisease Models, AnimalHypothermia, InducedMaleMiceMice, Inbred C57BLMotor SkillsNeuroprotective AgentsNeurotensinOligopeptidesABS-201Neuroprotective AgentsNeurotensinneurotensin type 1 receptorOligopeptidesReceptors, Neurotensin

Identifiers

PMID22459147
PMCPMC3382100
OpenAlexW2117173889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.